2025 Sponsors

Home » 2025 Sponsors

BioFIT is sponsored by companies from across the Life Sciences sector, reflecting the breadth of the event’s content, participants and partners.
Be one of them, contact us for further details.

PLATINUM SPONSOR

Globe Linkedin Twitter Facebook Instagram

Zoetis

Zoetis is the world’s leading animal health company. Our purpose is to nurture our world and humankind by advancing care for animals. After more than 70 years innovating ways to predict, prevent, detect, and treat animal illness, we continue to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. A Fortune 500 company, we generated revenue of $8.5 billion in 2023 with ~14,100 employees. For more, visit http://www.zoetis.com

Partnering with Zoetis

We strive to be the partner of choice in the vibrant and growing animal health industry. We collaborate with partners across the life sciences industries and academia, at any stage of development, from early research to commercial products – all with a shared interest in developing innovative solutions to improve the health and wellbeing of animals and the people who care for them.

Our areas of partnering interest

Livestock health
Companion animal therapeutics, including osteoarthritis, chronic pain, renal health, allergy and dermatitis
Preventatives
Diagnostics and Genetics
Platform technologies in biopharma, formulation, biomarkers and target discovery
Digital and Data Solutions

Gold Sponsor

SILVER SPONSORS

Globe Linkedin Twitter Facebook Instagram

Boehringer Ingelheim

As an independent company active in both human and animal health, Boehringer Ingelheim has learned over generations that the challenging path towards health innovation requires long-term commitment, resilience, and transformative action. Decades of cutting-edge science and innovation has enabled us to deliver many pioneering breakthroughs in some of the most devastating diseases and challenging areas we face globally. Continuing this journey hinges on collaboration.

We believe that working together with our global community of partners brings critical diversity to innovation and accelerates the next breakthroughs in human and animal health that will transform lives now and in generations to come. This collective power, in the tireless pursuit of science and solutions, enables us to build together a healthier, more sustainable, and equitable tomorrow.

Globe Linkedin Twitter Facebook Instagram

X’Prochem

Founded in 2012, X’PROCHEM is a CRO (Contract Research Organization) specializied in chemical protein synthesis.

We design and produce therapeutic proteins for our pharmaceutical and biotech partners. We manufacture complex and highly customized proteins up to 400 amino acids (40 kDa) by using an automated process.

BRONZE SPONSORS

Globe Linkedin Twitter Facebook Instagram

Ipsen

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 100 countries.

Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information, visit www.ipsen.com.

Our partnering team look forward to seeing you.

Globe Linkedin Twitter Facebook Instagram

MSD

MSD’s success stems from translating research into life-saving medical breakthroughs. From our development of the first measles and mumps vaccines to treatments for cancer and diabetes, we’ve become an industry leader in bringing innovative new medicines to patients. Approximately half of our pipeline is attributable to acquisitions, alliance partnerships and patents with our team executing 76 significant business development transactions in 2023. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life. Learn more at www.merck.com/licensing.

Globe Linkedin Twitter Facebook Instagram

Roche

Roche is a leading healthcare company and is heavily investing into R&D, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the CNS. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. Our Pharma Partnering team provides comprehensive BD and alliance management support for Roche and Genentech’s R&D units and the broader pharmaceutical division. Alongside the broad internal pipeline, external innovation has always been a critical component of our R&D strategy.

Globe Linkedin Twitter Facebook Instagram

Roquette

Roquette is a family-owned global leader in plant-based ingredients, and a leading provider of pharmaceutical excipients.

Founded in 1933, the company currently operates in more than 100 countries, has a turnover of 5 billion euros, and employs more than 10,000 people worldwide.

Life and nature have been our sources of inspiration for decades. All our raw materials are of natural origin. From them we develop a diverse portfolio of versatile and reliable excipients for the pharmaceutical, nutraceutical and biopharmaceutical markets.

Globe Linkedin Twitter Facebook Instagram

Transpharmation

Transpharmation is an accredited preclinical contract research organization specializing in translational pharmacology across various therapeutic areas. We offer neuroscience and animal health expertise, using behavioral, electrophysiological and protein-based biomarker assays to help clients benchmark compounds. Committed to on-time data delivery and flexible, customized solutions we support clients in optimizing preclinical assets for the development of life-changing medicines.

Globe Linkedin Twitter Facebook Instagram

WuXi AppTec

WuXi AppTec is a full-service provider of open-access capabilities and technology that enables customers worldwide to advance discoveries in the health sciences and deliver treatment to those in need.

CONTRIBUTING SPONSORS

Globe Linkedin Twitter Facebook Instagram

Captech Santé Nutrition

Launched in 2021, Captech Santé, is an early-stage fund, investing in projects in Biotech, Medtech, Digital Health and Nutrition. With a capital of €35 to €40 million, the fund invests in Seed or Series A. Thanks to its expertise and integration in the healthcare ecosystem, Captech supports its investments over the long term, and co-invests with international funds.

Globe Linkedin Twitter Facebook Instagram

Elanco

Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet.

Globe Linkedin Twitter Facebook Instagram

Innobiochips

Because improved diagnostic solutions contribute to a more precise and personalized medicine and improve the quality of life for patients worldwide, Innobiochips provides disruptive technologies to improve the accuracy, quality and sustainability of in vitro diagnostic approaches.

Globe Linkedin Twitter Facebook Instagram

MedTech Twente

The smart manufacturing industry (High Tech Systems and Materials) is characteristic for the Twente region in East-Netherlands. The World Trade Center Twente is building a MedTech cluster together with the Techmed Center at the University and companies in the medical technology sector.